U.S. Markets closed

Humanigen, Inc. (KBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.19+0.46 (+26.81%)
At close: 3:38PM EDT
People also watch
PBMDCANFMCURSPHSAQXP
Full screen
Previous Close1.73
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume13,445
Market Cap32.8M
BetaN/A
PE Ratio (TTM)-1.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal23 days ago

    [$$] Martin Shkreli’s Former Company Loses Race for FDA Approval

    Humanigen, a drug-development firm run briefly by convicted fraudster Martin Shkreli, lost out this week in a competition for fast-track regulatory treatment for a drug to treat Chagas' disease, a dangerous ...

  • Forbes7 months ago

    Rare Diseases Patients Need More Than Miracles And Trumpcare

    Rare Disease Week was rapidly followed by more proposals to gut the ACA healthcare and the FDA, immigration and travel bans which will decimate research and healthcare (as well as being needless and cruel), and reduce research budgets. How does this help patients?

  • We're sorry this is all we were able to find about this topic.